Rapid Micro Biosystems Inc (RPID) posted a Q4 2025 GAAP net loss of $0.28 per share. The company generated $11.3M in revenue for the quarter.
The life sciences technology company provides products for detecting microbial contamination in pharmaceutical, medical device, and personal care manufacturing. Rapid Micro Biosystems operates in the United States, Germany, Switzerland, Japan, and other international markets through its Growth Direct platform.
The company’s platform includes the growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
A detailed analysis of Rapid Micro Biosystems Inc’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.